Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Profit After Tax (2017 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Profit After Tax of $1.31 for Q1 2026, down 59.06% year-over-year from $3.2 in Q1 2025, and up 100.0% quarter-over-quarter from -$9.3 million in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Profit After Tax (2017 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Profit After Tax for 10 consecutive years, with $1.31 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Profit After Tax fell 59.06% year-over-year to $1.31; the TTM figure through Mar 2026 stood at $8.3 million (up 160.46% YoY), while the FY2025 annual figure was -$6.1 million, up 42.09% from the prior year.
  • Profit After Tax grew to $1.31 in Q1 2026 per SLGL's latest filing, from -$9.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $11.6 million in Q2 2025 and bottomed at -$15.3 million in Q4 2024.
  • Historically, Profit After Tax has averaged -$793940.7 across 5 years, with a median of $0.43 in 2023.
  • Annual changes were most pronounced in 2023 — Profit After Tax jumped 59699999900.0% — and 2024, when it slumped 216.67%.
  • Sol-Gel Technologies' Profit After Tax stood at -$14.9 million in 2022, then surged by 67.59% to -$4.8 million in 2023, then plunged by 216.67% to -$15.3 million in 2024, then jumped by 39.49% to -$9.3 million in 2025, then jumped by 100.0% to $1.31 in 2026.
  • Business Quant data shows SLGL's Profit After Tax at $1.31 in Q1 2026, -$9.3 million in Q4 2025, and $5.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - 3.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.68 Mn
Mar 31, 2026 3.73 Mn
Dec 31, 2025 9.27 Mn
Sep 30, 2025 -5.94 Mn
Jun 30, 2025 11.61 Mn
Mar 31, 2025 8.81 Mn
Dec 31, 2024 15.31 Mn
Sep 30, 2024 -366,000.00
Jun 30, 2024 1.98 Mn
Mar 31, 2024 6.34 Mn
Dec 31, 2023 49.64 Mn
Sep 30, 2023 -5.71 Mn
Jun 30, 2023 -5.97 Mn
Mar 31, 2023 10.72 Mn
Dec 31, 2022 24.06 Mn
Sep 30, 2022 -3.41 Mn
Jun 30, 2022 134,000.00
Mar 31, 2022 5.60 Mn
Dec 31, 2021 14.03 Mn
Sep 30, 2021 1.29 Mn